Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1984. Upgrade now.
Date Value
September 30, 2024 20.30B
June 30, 2024 25.48B
March 31, 2024 26.22B
December 31, 2023 22.93B
September 30, 2023 23.51B
June 30, 2023 28.50B
March 31, 2023 24.61B
December 31, 2022 22.28B
September 30, 2022 34.08B
June 30, 2022 32.57B
March 31, 2022 30.39B
December 31, 2021 31.61B
September 30, 2021 31.00B
June 30, 2021 25.31B
March 31, 2021 24.62B
December 31, 2020 25.18B
September 30, 2020 30.78B
June 30, 2020 19.14B
March 31, 2020 18.02B
December 31, 2019 19.29B
September 30, 2019 17.94B
June 30, 2019 15.28B
March 31, 2019 15.34B
December 31, 2018 19.69B
September 30, 2018 19.36B
Date Value
June 30, 2018 18.14B
March 31, 2018 15.20B
December 31, 2017 18.30B
September 30, 2017 16.23B
June 30, 2017 12.85B
March 31, 2017 39.34B
December 31, 2016 41.91B
September 30, 2016 40.43B
June 30, 2016 42.58B
March 31, 2016 39.86B
December 31, 2015 38.38B
September 30, 2015 37.31B
June 30, 2015 33.95B
March 31, 2015 31.32B
December 31, 2014 33.09B
September 30, 2014 33.00B
June 30, 2014 31.62B
March 31, 2014 29.39B
December 31, 2013 29.21B
September 30, 2013 25.23B
June 30, 2013 25.13B
March 31, 2013 21.67B
December 31, 2012 21.09B
September 30, 2012 19.77B
June 30, 2012 16.92B

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

18.02B
Minimum
Mar 2020
34.08B
Maximum
Sep 2022
25.79B
Average
25.25B
Median

Cash and Short Term Investments (Quarterly) Benchmarks

Amgen Inc 9.011B
Eli Lilly and Co 3.518B
Merck & Co Inc 14.59B
Pfizer Inc 9.952B
AbbVie Inc 7.285B